Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Alternet Systems, Inc. (ALYI): Bridging the Gap between Merchants and Consumers via Payment Technology Solutions

Smartphones are attached to everyone’s hip in today’s world. Mobile payment solutions, such as PayPal (NASDAQ: PYPL) and Apple Pay, are being integrated into every new technology that emerges. When you launch an online store, the most important function of the website is the payment option. Today’s world moves at light speed and consumers demand […]

OncBioMune Pharmaceuticals, Inc. (OBMP) Preparing to Commence Phase II Clinical Study of ProscaVax™ Cancer Vaccine

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. The company’s lead product candidate, ProscaVax™, is a novel prostate cancer vaccine that’s scheduled to commence a phase II clinical trial in the coming weeks after recording promising results in its phase I clinical trial, which […]

Content Checked Holdings, Inc.’s (CNCK) SugarChecked App Featured in Article on #LatinaGeeks

Content Checked Holdings, Inc. (OTCQB: CNCK), the company behind the innovative ContentChecked, MigraineChecked and SugarChecked mobile applications, has made tremendous strides toward increasing its brand awareness in recent months by contributing helpful tidbits for living a healthier life in articles on some of the web’s top nutrition- and technology-focused news sites. Earlier this week, the […]

Lightlake Therapeutics, Inc. (LLTP) Targeting Addictions and Related Disorders with Platform of Innovative Intranasal Naloxone Solutions

Lightlake Therapeutics, Inc. (OTCQB: LLTP) is a specialty pharmaceutical company engaged in the development of pharmacological treatments for substance abuse, addiction and eating disorders. In December 2014, the company entered into a global licensing deal with a subsidiary of Adapt Pharma Limited to develop and commercialize Lightlake’s innovative intranasal naloxone opioid overdose reversal treatment, NARCAN® […]

Halitron, Inc. (HAON) Follows Strategic Business Model to Acquire PRD Holdings and PiecesInPlaces

Aligned with its business model to acquire and roll-up sales, marketing, and manufacturing companies, Halitron, Inc. (OTC: HAON) this morning announced its fourth and fifth acquisitions since 2015: PRD Holdings, Inc., a U.S. holding company for a Mexico-based factory; and PiecesInPlaces, a leading direct marketing brand. PRD Holdings owns several factory investments in Mexico. These […]

Content Checked Holdings, Inc. (CNCK) Empowers Consumers

After a triumphant initial launch of its ContentChecked app, Content Checked Holdings, Inc. (OTCQB: CNCK) is looking ahead. The company has set its sights on a wider release of its ContentChecked app and its other apps (SugarChecked and MigraineChecked) in order to further its impact. What problem is Content Checked interested in solving? The company […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Driving Innovation in Photodynamic Therapy Potential in Oncology, Dermatology

February 10, 2026

From lab research to clinical application, photodynamic therapy (“PDT”) is emerging as a powerful treatment approach that uses light and chemistry to selectively target diseased tissue. As this modality gains attention for its precision and safety profile, Soligenix (NASDAQ: SNGX) is developing light-activated therapies designed to treat cutaneous T-cell lymphoma (“CTCL”) and other inflammatory skin […]

Rotate your device 90° to view site.